Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Ofatumumab versus Teriflunomide in Multiple SclerosisThe New England journal of medicine, 2020-08, Vol.383 (6), p.546-557 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917246 ;PMID: 32757523Full text available |
2 |
Material Type: Article
|
![]() |
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 studyThe Lancet (British edition), 2018-03, Vol.391 (10127), p.1263-1273 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 31, 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)30475-6 ;PMID: 29576505Full text available |
3 |
Material Type: Article
|
![]() |
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extensionLancet neurology, 2018-05, Vol.17 (5), p.405-415 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(18)30069-3 ;PMID: 29545067Full text available |
4 |
Material Type: Article
|
![]() |
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic StrokeThe New England journal of medicine, 2013-03, Vol.368 (12), p.1092-1100 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1301440 ;PMID: 23514286 ;CODEN: NEJMAGFull text available |
5 |
Material Type: Article
|
![]() |
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in MiceTranslational stroke research, 2016-12, Vol.7 (6), p.535-547 [Peer Reviewed Journal]The Author(s) 2016 ;ISSN: 1868-4483 ;EISSN: 1868-601X ;DOI: 10.1007/s12975-016-0496-0Digital Resources/Online E-Resources |
6 |
Material Type: Article
|
![]() |
Challenges in randomized controlled trials and emerging multiple sclerosis therapeuticsNeuroscience bulletin, 2015-12, Vol.31 (6), p.745-754 [Peer Reviewed Journal]Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg 2015 ;ISSN: 1673-7067 ;EISSN: 1995-8218 ;DOI: 10.1007/s12264-015-1560-6 ;PMID: 26480875Full text available |
7 |
Material Type: Article
|
![]() |
Control of microglial neurotoxicity by the fractalkine receptorNature neuroscience, 2006-07, Vol.9 (7), p.917-924 [Peer Reviewed Journal]COPYRIGHT 2006 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2006 ;ISSN: 1097-6256 ;EISSN: 1546-1726 ;DOI: 10.1038/nn1715 ;PMID: 16732273 ;CODEN: NANEFNFull text available |
8 |
Material Type: Article
|
![]() |
Isolation of murine microglial cells for RNA analysis or flow cytometryNature protocols, 2006-11, Vol.1 (4), p.1947-1951 [Peer Reviewed Journal]COPYRIGHT 2006 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2006 ;ISSN: 1754-2189 ;EISSN: 1750-2799 ;DOI: 10.1038/nprot.2006.327 ;PMID: 17487181Full text available |
9 |
Material Type: Article
|
![]() |
Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patientsAnnals of neurology, 2007-07, Vol.62 (1), p.34-39 [Peer Reviewed Journal]Copyright © 2007 American Neurological Association ;2007 INIST-CNRS ;ISSN: 0364-5134 ;EISSN: 1531-8249 ;DOI: 10.1002/ana.21085 ;PMID: 17328067 ;CODEN: ANNED3Full text available |
10 |
Material Type: Article
|
![]() |
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulationImmunological reviews, 2000-10, Vol.177 (1), p.52-67 [Peer Reviewed Journal]ISSN: 0105-2896 ;EISSN: 1600-065X ;DOI: 10.1034/j.1600-065X.2000.17709.x ;PMID: 11138785Full text available |
11 |
Material Type: Patent
|
![]() |
Water quality monitoring device and monitoring method for drainage of sewage treatment plantDigital Resources/Online E-Resources |
12 |
Material Type: Article
|
![]() |
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimodNeurology, 2015-09, Vol.85 (11), p.1001-1003 [Peer Reviewed Journal]2015 American Academy of Neurology ;ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000001929 ;PMID: 26291283Full text available |
13 |
Material Type: Article
|
![]() |
Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitisJournal of leukocyte biology, 2005-02, Vol.77 (2), p.229-237 [Peer Reviewed Journal]2005 Society for Leukocyte Biology ;ISSN: 0741-5400 ;EISSN: 1938-3673 ;DOI: 10.1189/jlb.0804465 ;PMID: 15539456Full text available |
14 |
Material Type: Article
|
![]() |
Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in MiceThe Journal of neuroscience, 2002-12, Vol.22 (24), p.10633-10642 [Peer Reviewed Journal]Copyright © 2002 Society for Neuroscience 2002 ;ISSN: 0270-6474 ;EISSN: 1529-2401 ;DOI: 10.1523/jneurosci.22-24-10633.2002 ;PMID: 12486156Full text available |
15 |
Material Type: Article
|
![]() |
Advances in the Immune Pathogenesis and Treatment of Multiple SclerosisCentral nervous system agents in medicinal chemistry, 2009-03, Vol.9 (1), p.20-31 [Peer Reviewed Journal]ISSN: 1871-5249 ;DOI: 10.2174/187152409787601923Full text available |
16 |
Material Type: Article
|
![]() |
Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs (P7-3.011)Neurology, 2023-04, Vol.100 (17_supplement_2) [Peer Reviewed Journal]ISSN: 0028-3878 ;EISSN: 1526-632X ;DOI: 10.1212/WNL.0000000000203085Full text available |
17 |
Material Type: Article
|
![]() |
Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot TrialCirculation (New York, N.Y.), 2015-09, Vol.132 (12), p.1104-1112 [Peer Reviewed Journal]2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.115.016371 ;PMID: 26202811Full text available |
18 |
Material Type: Article
|
![]() |
Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind studyLancet neurology, 2014-07, Vol.13 (7), p.657-665 [Peer Reviewed Journal]Copyright © 2014 Elsevier Ltd. All rights reserved. ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(14)70068-7 ;PMID: 24794721Full text available |
19 |
Material Type: Article
|
![]() |
Ublituximab versus Teriflunomide in Relapsing Multiple SclerosisThe New England journal of medicine, 2022-08, Vol.387 (8), p.704-714 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2201904Full text available |
20 |
Material Type: Article
|
![]() |
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trialLancet neurology, 2021-09, Vol.20 (9), p.729-738 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(21)00237-4 ;PMID: 34418400Full text available |